These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14553874)

  • 1. Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease.
    Yock CA; Boothroyd DB; Owens DK; Garber AM; Hlatky MA
    Am J Med; 2003 Oct; 115(5):382-9. PubMed ID: 14553874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projected long-term costs of coronary stenting in multivessel coronary disease based on the experience of the Bypass Angioplasty Revascularization Investigation (BARI).
    Yock CA; Boothroyd DB; Owens DK; Winston C; Hlatky MA
    Am Heart J; 2000 Oct; 140(4):556-64. PubMed ID: 11011328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing cost aspects of coronary artery bypass graft surgery with coronary artery stenting.
    Birim Ö; Bogers AJ; Kappetein AP
    J Cardiovasc Surg (Torino); 2012 Oct; 53(5):641-50. PubMed ID: 22252542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial.
    Magnuson EA; Farkouh ME; Fuster V; Wang K; Vilain K; Li H; Appelwick J; Muratov V; Sleeper LA; Boineau R; Abdallah M; Cohen DJ;
    Circulation; 2013 Feb; 127(7):820-31. PubMed ID: 23277307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model.
    Cohen DJ; Breall JA; Ho KK; Kuntz RE; Goldman L; Baim DS; Weinstein MC
    Circulation; 1994 Apr; 89(4):1859-74. PubMed ID: 8149551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery.
    Cohen DJ; Breall JA; Ho KK; Weintraub RM; Kuntz RE; Weinstein MC; Baim DS
    J Am Coll Cardiol; 1993 Oct; 22(4):1052-9. PubMed ID: 8409040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
    Hlatky MA; Boothroyd DB; Melsop KA; Kennedy L; Rihal C; Rogers WJ; Venkitachalam L; Brooks MM;
    Circulation; 2009 Dec; 120(25):2550-8. PubMed ID: 19920002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery.
    Rao C; Aziz O; Panesar SS; Jones C; Morris S; Darzi A; Athanasiou T
    BMJ; 2007 Mar; 334(7594):621. PubMed ID: 17337457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.
    Reynolds MR; Neil N; Ho KK; Berezin R; Cosgrove RS; Lager RA; Sirois C; Johnson RG; Cohen DJ
    Am Heart J; 2003 Feb; 145(2):334-42. PubMed ID: 12595853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of coronary revascularisation.
    Birim O; Bogers AJ; Kappetein AP
    EuroIntervention; 2010 Feb; 5(7):763-7. PubMed ID: 20142188
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
    Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
    Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Eisenstein EL; Leon MB; Kandzari DE; Mauri L; Edwards R; Kong DF; Cowper PA; Anstrom KJ;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1199-207. PubMed ID: 20129546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
    Cohen DJ; Bakhai A; Shi C; Githiora L; Lavelle T; Berezin RH; Leon MB; Moses JW; Carrozza JP; Zidar JP; Kuntz RE;
    Circulation; 2004 Aug; 110(5):508-14. PubMed ID: 15262844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy.
    de Vries SO; Visser K; de Vries JA; Wong JB; Donaldson MC; Hunink MG
    Radiology; 2002 Jan; 222(1):25-36. PubMed ID: 11756701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Can PCI with drug-eluting stents replace coronary artery bypass surgery? A comparative economic analysis regarding both therapeutic options based on clinical 12-month data reflecting the German social health care insurance system].
    Fricke FU; Silber S
    Herz; 2005 Jun; 30(4):332-8. PubMed ID: 15965811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) study.
    Srinivas VS; Brooks MM; Detre KM; King SB; Jacobs AK; Johnston J; Williams DO
    Circulation; 2002 Sep; 106(13):1627-33. PubMed ID: 12270854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The costs and quality-of-life outcomes of drug-eluting coronary stents: a systematic review.
    Groeneveld PW; Suh JJ; Matta MA
    J Interv Cardiol; 2007 Feb; 20(1):1-9. PubMed ID: 17300390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stent implantation as initial coronary interventional therapy? A theoretical model on clinical and economical consequences of in-stent restenosis].
    Pfund A; Wendland G; Baer F; Lauterbach K; Höpp HW
    Herz; 2000 Aug; 25(5):495-501. PubMed ID: 10992998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of coronary stenting in acute myocardial infarction: results from the stent primary angioplasty in myocardial infarction (stent-PAMI) trial.
    Cohen DJ; Taira DA; Berezin R; Cox DA; Morice MC; Stone GW; Grines CL
    Circulation; 2001 Dec; 104(25):3039-45. PubMed ID: 11748097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.